Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease

Documenti analoghi

• Response to the Letter Regarding “Diagnostic and Prognostic Performance of the Agile 3+ Score in Patients With Chronic Hepatitis B and Concurrent MASLD After Complete Viral Suppression With Nucleos(t)ide Analogues”
  di: Hongsheng Yu, et al.
  Pubblicazione: (2026)
• Diagnostic and Prognostic Performance of the Agile 3+ Score in Patients With Chronic Hepatitis B and Concurrent MASLD After Complete Viral Suppression With Nucleos(t)ide Analogues
  di: Hongsheng Yu, et al.
  Pubblicazione: (2025)
• Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
  di: Seung Kak Shin, et al.
  Pubblicazione: (2024)
• Comparison of the ability between dual‐energy X‐ray absorptiometry and bioelectrical impedance analysis for diagnosing low skeletal muscle mass and sarcopenia in patients with chronic liver disease
  di: Yuki Tamura, et al.
  Pubblicazione: (2024)
• Correction to “Hepatobiliary and Pancreatic: Challenges in the diagnosis of hepatic nodules in patients with alcoholic liver cirrhosis”
  Pubblicazione: (2024)